# Proteomics analysis of SARS-CoV-2 infected cell culture samples

# Live Resources

usegalaxy.eu
Input data Input data view view
PXD018241 history1 PXD018241 history1 view view
PXD018241 history2 PXD018241 history2 view view
PXD018241 history3 PXD018241 history3 view view
PXD018241 history4 PXD018241 history4 view view
PXD018241 history5 PXD018241 history5 view view
PXD018241 history6 PXD018241 history6 view view
PXD018241 history7 PXD018241 history7 view view
PXD018241 history8 PXD018241 history8 view view
PXD018241 history9 PXD018241 history9 view view
PXD018241 history10 PXD018241 history10 view view
PXD018241 history11 PXD018241 history11 view view
workflow workflow run run

# Description

Davidson et al used SARS-CoV-2 grown in Vero E6 cells to propagate the novel coronavirus and generate viral transcriptome and tandem mass spectrometry was used to investigate the proteome and phosphoproteome of the virally infected cells. The transcriptome was used as an input for an ORF-centric pipeline.Their analysis detected a 24 nt in-frame deletion in mRNA encoding the spike (S) glycoprotein and was predicted to remove a proposed furin cleavage site from the S glycoprotein. Tandem mass spectrometry identified over 500 viral peptides and 44 phosphopeptides in virus-infected cells, covering almost all proteins predicted to be encoded by the SARS-CoV-2 genome, including peptides unique to the deleted variant of the S glycoprotein. Mass spectrometry data was acquired on an Orbitrap Fusion Lumos mass spectrometer (Thermo Scientific) in data-dependent acquisition mode and deposited in ProteomeXchange repository (PXD018241). We were interested in using the mass spectrometry dataset and searching it against the viral proteome to detect viral peptides from these samples.

# Workflow

The Galaxy workflow includes RAW data conversion to MGF and mzML format. The MGF files are searched against the combined database of Human Uniprot proteome, contaminant proteins and SARS-Cov-2 proteins database using X!tandem, MSGF+, OMSSA search algorithms with SearchGUI and FDR and protein grouping using PeptideShaker. This resulted in detection of 579 peptides from SARS-CoV-2 proteins. The detected peptides were searched against NCBInr to ascertain that these peptides were specific to SARS-CoV-2 proteins. The detected peptides were later subjected to analysis by PepQuery and Lorikeet to ascertain the quality of peptide identification.

# Results

The COVID-19 positive patient samples detected 579 peptides from SARS-CoV-2 proteins.